Results

Total Results: 2,204 records

Showing results for "drugs".

321. Myasthenia Gravis | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/myasthenia-gravis
     Other drugs keep your body from making so many abnormal antibodies.

322. Raynaud's Disease | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/raynauds-disease
     Treatment for Raynaud's may include drugs to keep the blood vessels open.

323. Diagnosis and treatment of low back pain:Key questions:In patients with low back pain, what are the benefits and harms of identifying risk factors for chronicity and targeting treatment based on assessed… | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/diagnosis-and-treatment-of-low-back-painbr-key-questionsbr-olliin-patients-with-low-back-pain-what-are-the-benefits-and-harms-of-identifying-risk-factors-for-chronicity-and-targeting-treatment-based-on-assessed-riskliliin-pa
     November 01, 2017 - joint steroid injection, intradiscal methylene blue, intradiscal ozone, injections involving anti-TNF drugs … yes If yes, explain the specific technologies, devices, drugs, or interventions you would like to

324. Methods Research Report - Progression-Free Survival: What Does It Mean for Psychological Well-Being or Quality of Life? (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/survival-quality_research.pdf
     April 01, 2013 - List of Drugs Approved Using Studies With a Primary Endpoint of PFS Appendix D. … These drugs are not expected to provide the same objective response rates of earlier drugs, and instead … To answer KQ2 we identified a targeted sample of drugs. … For KQ2, a targeted search strategy included the identified drugs of interest—drugs approved for treatment … List of Drugs Approved Using Studies With a Primary Endpoint of PFS Oncology drugs for advanced

325. Interventions to Prevent Age-Related Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer's-Type Dementia | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/cognitive-decline/research-2017
     April 01, 2020 - therapy, vitamins, antihypertensive treatment, lipid lowering treatment, nonsteroidal anti-inflammatory drugs … (NSAIDs), antidementia drugs, diabetes treatment, and "other interventions."

326. Treatments for Acute Pain | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/treatments-acute-pain/research
     August 01, 2022 - Points Opioids are probably less effective than nonsteroidal anti-inflammatory drugs … Opioid therapy was probably less effective than nonsteroidal anti-inflammatory drugs (NSAIDs) for surgical

327. Fifth Journal Supplement on Research Methods: Patient-Centered Health Outcomes in Rare Diseases | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/rare-diseases-outcomes/overview
     October 01, 2019 - Application of a Policy Framework for the Public Funding of Drugs for Rare Diseases Winquist E, Coyle … Application of a Policy Framework for the Public Funding of Drugs for Rare Diseases.

328. Comparative Effectiveness of Analgesics To Reduce Acute Pain in the Prehospital Setting | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/acute-pain-ems/research
     January 01, 2022 - Key Messages As initial therapy in the prehospital setting: Nonsteroidal anti-inflammatory drugs provide … intravenously (IV) (low SOE), IV acetaminophen (APAP) (low SOE), or nonsteroidal anti-inflammatory drugs

329. Effective Health Care Program History | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/about/history
     January 01, 2022 - Research and Quality (AHRQ) to (1) conduct patient-centered outcomes research that investigates different drugs

330. #05 DEPRESSION (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/05_depression_potential_high_impact_2012-12-10.pdf
     January 01, 2012 - In the health care sector, horizon scanning pertains to identifying new (and new uses of existing) pharmaceuticals … Results The table below lists the seven topics for which (1) preliminary phase III data on drugs or … to several weeks, following a single infusion. 29,33,34 The drug was launched in 1966 by King Pharmaceuticals … Drugs Future 2009;34(3):217-21. 31. Thomson Reuters Integrity [database online]. … In: Drugs@FDA [internet]. Silver Spring (MD): U.S.

331. What do we know about how evidence of harm and benefit is communicated in other countries? (ppt file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/communicating_risk_international_king.ppt
     January 01, 2005 - Methods Literature Review Medline--1996-2006 Search Terms: Patient Education Evidence-based Medicine Pharmaceutical … Preparations Consumer Information Products from Other Countries Description Compare characteristics

332. The American College of Chest Physicians (ACCP) proposes to update the following 4 guideline topics from the 2006 publication on the Diagnosis and Management of Cough: ACCP Evidence-Based Clinical Practice Guidelines.1 1. Assessing Cough… | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/the-american-college-of-chest-physicians-accp-proposes-to-update-the-following-4-guideline-topics-from-the-2006-publication-on-the-diagnosis-and-management-of-cough-accp-evidence-based-clinical-practice-guidelines1-1-assessi
     November 01, 2017 - yes If yes, explain the specific technologies, devices, drugs, or interventions you would like to … Complications caused by coughing as well as adverse drugs reactions due to cough suppressants or protussive … manage the unexplained, refractory chronic cough in adults, and 4) to know which cough antisuppressant drugs

333. Comparative Effectiveness of Drug Therapy for Rheumatoid Arthritis in Adults – An Update to the 2007 Report | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/rheumatoid-arthritis-medicine/research-protocol
     December 01, 2019 - Available therapies for RA include corticosteroids, oral disease-modifying antirheumatic drugs (DMARDs … Finally, very little is known about the benefits or risks of these drugs AMONG different patient subgroups … review did not include certolizumab pegol, golimumab, and tocilizumab (listed above), because these drugs … Simponi® Tocililizumab Actemra®, RoActemrai® Comparators: For all KQs: all review drugs

334. 08 Functional Limitations Potential High Impact 2012-12-10 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/08_functional_limitations_potential_high_impact_2012-12-10.pdf
     January 01, 2012 - Drugs Today 2010;46(1):49-67. 3. Sorbera LA, Dulsat C, Rosa E. … East Hanover (NJ): Novartis Pharmaceuticals Corporation; 2011 Jul. 21 p. … Drugs Future 2010;35(2):93-7. … Drugs Today (Barc) 2010 Nov;46(11):815-22. PMID: 21225020 30. … Mountain View (CA): MAP Pharmaceuticals, Inc.; [accessed 2011 Jan 6]. [1 p].

335. Nominate Topics To Be Addressed by Upcoming AHRQ Evidence-based Practice Center Program Evidence Reviews: Deadline March 30, 2024 | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/news/nominate-topics-addressed
     February 01, 2024 - Its publications help inform healthcare decision making on drugs, devices, surgeries, and approaches

336. Nominate Topics To Be Addressed by Upcoming AHRQ Evidence-based Practice Center Program Systematic Reviews: Deadline June 5, 2023 | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/news/nominate-topics
     May 01, 2023 - Its publications help inform healthcare decision-making on drugs, devices, surgeries, and approaches

337. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … Results The table below lists the two topics for which (1) preliminary phase III data on drugs, phase … A third topic that was in the December 2013 report, the oral tablet ivacaftor (Kalydeco™, Vertex Pharmaceuticals

338. Newer Medications for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/prostatic-hyperplasia-medications_research-protocol.pdf
     April 21, 2015 - Prescribing behavior has changed with the approval of new drugs and the availability of new evidence … for efficacy, comparative effectiveness, and harms.6 Table 1 provides a list of drugs commonly used … and enlarged prostates with either agent are supported by systematic reviews.10, 13 Recently, newer drugs … A new AB, silodosin, was approved for the treatment of BPH in 2008.7 Several anticholinergics drugs … symptoms such as urgency, frequency, and nocturia, which may or may not be causally related.15 These drugs

339. Treatment for Restless Legs Syndrome Disposition of Comments Report (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/restless-legs_disposition-comments.pdf
     November 27, 2012 - Peer Reviewer #1 Introduction The gabapentin- pregabalin group of drugs is called “GABA analogs”. … This complication can occur in 9- 17% of RLS patients using these drugs. … First, FDA approved drugs include rotigotine (probably approved after submission) and gabapentin enacarbil … was not identified as a therapy commonly used and we identified no eligible studies examining these drugs … Since most of the report does not actually compare drugs, why can these not be included?

340. | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/D
     Diverticulosis and Diverticulitis Domestic Violence Down Syndrome Drug Abuse Drug Reactions Drugs